Carmine Therapeutics Company
Carmine Therapeutics is developing novel types of gene therapies that utilize extracellular vesicles (EVs) produced in the laboratory.
Technology:
Cardiovascular Disorders
Industry:
Gene therapy
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2019
Employees Number:
11-50
Funding Status:
Seed
Total Funding:
3400000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership